NEW YORK (GenomeWeb News) — Sequenom today said it has tapped Tata Consultancy Services to develop software products to “empower its customers to discover, analyze, and report genetic information.”
The software will include components that provide access to public and private life sciences databases; integrate bioinformatics and computational biology tools within the framework; and enable the design and execution of workflows.
It will be designed to enable researchers to “create and manage projects for planning user tasks, storing user data, and analyses,” Sequenom said in a statement.
TCS' signal-processing and life sciences group will develop software modules for “improving interfaces to, and signal conditioning of, mass spectrometer data,” Sequenom said.
“The emerging genetics and life sciences sectors present a significant growth opportunity for TCS as it helps us leverage the innovation embedded in this organization,” TCS CEO S. Ramadorai said in the statement.
All development under the agreement will conform to US Food and Drug Administration regulatory standards, Sequenom said.
Financial terms of the agreement were not disclosed.